BG Medicine Announces Publication of First Study on Use of Galectin-3 in ... MarketWatch (press release) The galectin-3 CORONA study was designed to assess whether baseline galectin-3 levels could distinguish a group of patients with heart failure who would derive a clinical benefit from rosuvastatin treatment. Rosuvastatin, known under the brand name ... BG Medicine Publishes Study On Use Of Galectin-3 In Drug Therapy In HeartFailure BG MEDICINE, INC. : Announces Availability of Galectin-3 Diagnostic Testing ... |
